Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer

doi:10.1001/jama.2016.16918

Comment

. 2017 Feb 7;317(5):531-534.

doi: 10.1001/jama.2016.16918.

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer

Allison W Kurian¹, Kent A Griffith², Ann S Hamilton³, Kevin C Ward⁴, Monica Morrow⁵, Steven J Katz⁶, Reshma Jagsi⁷

Affiliations

¹ Stanford University, Department of Medicine, Stanford, California.
² University of Michigan, Department of Biostatistics, Ann Arbor.
³ University of Southern California, Department of Preventive Medicine, Los Angeles.
⁴ Emory University, Department of Epidemiology, Atlanta, Georgia.
⁵ Memorial Sloan-Kettering Cancer Center, Department of Surgery, New York, New York.
⁶ University of Michigan, Department of Internal Medicine, Ann Arbor.
⁷ University of Michigan, Department of Radiation Oncology, Ann Arbor.

PMID: 28170472
PMCID: PMC5530866
DOI: 10.1001/jama.2016.16918

Comment

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer

Allison W Kurian et al. JAMA. 2017.

. 2017 Feb 7;317(5):531-534.

doi: 10.1001/jama.2016.16918.

Authors

Allison W Kurian¹, Kent A Griffith², Ann S Hamilton³, Kevin C Ward⁴, Monica Morrow⁵, Steven J Katz⁶, Reshma Jagsi⁷

Affiliations

¹ Stanford University, Department of Medicine, Stanford, California.
² University of Michigan, Department of Biostatistics, Ann Arbor.
³ University of Southern California, Department of Preventive Medicine, Los Angeles.
⁴ Emory University, Department of Epidemiology, Atlanta, Georgia.
⁵ Memorial Sloan-Kettering Cancer Center, Department of Surgery, New York, New York.
⁶ University of Michigan, Department of Internal Medicine, Ann Arbor.
⁷ University of Michigan, Department of Radiation Oncology, Ann Arbor.

PMID: 28170472
PMCID: PMC5530866
DOI: 10.1001/jama.2016.16918

No abstract available

PubMed Disclaimer

Comment on

Multigene Panel Testing in Oncology Practice: How Should We Respond?
Kurian AW, Ford JM. Kurian AW, et al. JAMA Oncol. 2015 Jun;1(3):277-8. doi: 10.1001/jamaoncol.2015.28. JAMA Oncol. 2015. PMID: 26181167 No abstract available.

Cited by

Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer.
Pederson HJ, Narod SA. Pederson HJ, et al. BJC Rep. 2024 Oct 1;2(1):73. doi: 10.1038/s44276-024-00099-x. BJC Rep. 2024. PMID: 39516714 Free PMC article. Review.
BRCA genetic testing and counseling in breast cancer: how do we meet our patients' needs?
Dubsky P, Jackisch C, Im SA, Hunt KK, Li CF, Unger S, Paluch-Shimon S. Dubsky P, et al. NPJ Breast Cancer. 2024 Sep 5;10(1):77. doi: 10.1038/s41523-024-00686-8. NPJ Breast Cancer. 2024. PMID: 39237557 Free PMC article. Review.
Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system.
Raper AC, Weathers BL, Drivas TG, Ellis CA, Kripke CM, Oyer RA, Owens AT, Verma A, Wileyto PE, Wollack CC, Zhou W, Ritchie MD, Schnoll RA, Nathanson KL. Raper AC, et al. Implement Sci. 2024 Aug 19;19(1):61. doi: 10.1186/s13012-024-01385-5. Implement Sci. 2024. PMID: 39160614 Free PMC article. Clinical Trial.
Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
Katz SJ, Abrahamse P, Furgal A, Hodan R, Tocco RS, Ward KC, Hamilton AS, Wallner LP, Kurian AW. Katz SJ, et al. J Clin Oncol. 2024 Sep 10;42(26):3123-3129. doi: 10.1200/JCO.24.00122. Epub 2024 Jul 15. J Clin Oncol. 2024. PMID: 39008790
Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach.
Abdel-Razeq H, Tamimi F, Iweir S, Sharaf B, Abdel-Razeq S, Salama O, Edaily S, Bani Hani H, Azzam K, Abaza H. Abdel-Razeq H, et al. Sci Rep. 2024 Jun 4;14(1):12820. doi: 10.1038/s41598-024-63300-8. Sci Rep. 2024. PMID: 38834641 Free PMC article.

See all "Cited by" articles

References

1. Kurian AW, Ford JM. Multigene Panel Testing in Oncology Practice: How Should We Respond? JAMA Oncol. 2015 Jun 1;1(3):277–278. - PubMed
1. Delikurt T, Williamson GR, Anastasiadou V, Skirton H. A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Hum Genet. 2015 Jun;23(6):739–745. - PMC - PubMed
1. Daly MB, Pilarski R, Axilbund JE, et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw. 2016 Feb;14(2):153–162. - PubMed
1. Kurian AW, Gong GD, Chun NM, et al. Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol. 2008 Oct 10;26(29):4752–4758. - PMC - PubMed
1. Tung N, Lin NU, Kidd J, et al. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol. 2016 Mar 14; - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Kurian AW, Ford JM. Multigene Panel Testing in Oncology Practice: How Should We Respond? JAMA Oncol. 2015 Jun 1;1(3):277–278. - PubMed

[2] Kurian AW, Ford JM. Multigene Panel Testing in Oncology Practice: How Should We Respond? JAMA Oncol. 2015 Jun 1;1(3):277–278. - PubMed

[3] Delikurt T, Williamson GR, Anastasiadou V, Skirton H. A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Hum Genet. 2015 Jun;23(6):739–745. - PMC - PubMed

[4] Delikurt T, Williamson GR, Anastasiadou V, Skirton H. A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Hum Genet. 2015 Jun;23(6):739–745. - PMC - PubMed

[5] Daly MB, Pilarski R, Axilbund JE, et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw. 2016 Feb;14(2):153–162. - PubMed

[6] Daly MB, Pilarski R, Axilbund JE, et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. J Natl Compr Canc Netw. 2016 Feb;14(2):153–162. - PubMed

[7] Kurian AW, Gong GD, Chun NM, et al. Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol. 2008 Oct 10;26(29):4752–4758. - PMC - PubMed

[8] Kurian AW, Gong GD, Chun NM, et al. Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol. 2008 Oct 10;26(29):4752–4758. - PMC - PubMed

[9] Tung N, Lin NU, Kidd J, et al. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol. 2016 Mar 14; - PMC - PubMed

[10] Tung N, Lin NU, Kidd J, et al. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol. 2016 Mar 14; - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer

Affiliations

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical